123 related articles for article (PubMed ID: 2111246)
21. Pharmacokinetic considerations in the design of better and safer new antiepileptic drugs.
Bialer M
J Control Release; 1999 Nov; 62(1-2):187-92. PubMed ID: 10518650
[TBL] [Abstract][Full Text] [Related]
22. Structure-pharmacokinetic relationships in a series of short fatty acid amides that possess anticonvulsant activity.
Haj-Yehia A; Bialer M
J Pharm Sci; 1990 Aug; 79(8):719-24. PubMed ID: 2231336
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and antiepileptic activity of valproyl hydroxamic acid derivatives.
Levi M; Yagen B; Bialer M
Pharm Res; 1997 Feb; 14(2):213-7. PubMed ID: 9090712
[TBL] [Abstract][Full Text] [Related]
24. Disposition of two tetramethylcyclopropane analogues of valpromide in the brain, liver, plasma and urine of rats.
Blotnik S; Bergman F; Bialer M
Eur J Pharm Sci; 1998 Apr; 6(2):93-8. PubMed ID: 9795021
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and anticonvulsant activity of three monoesteric prodrugs of valproic acid.
Badir K; Haj-Yehia A; Vree TB; van der Kleijn E; Bialer M
Pharm Res; 1991 Jun; 8(6):750-3. PubMed ID: 2062805
[TBL] [Abstract][Full Text] [Related]
26. Stereoselective pharmacokinetic analysis and antiepileptic activity of N-2-hydroxypropyl valpromide, a central nervous system--active chiral valproylamide.
Wasserman M; Yagen B; Blotnik S; Papo N; Bialer M
Ther Drug Monit; 2001 Aug; 23(4):414-20. PubMed ID: 11477326
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of valpromide in dogs after various modes of administration.
Bialer M; Rubinstein A
Biopharm Drug Dispos; 1984; 5(2):177-83. PubMed ID: 6430363
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of valpromide after oral administration of a solution and a tablet to healthy volunteers.
Bialer M; Rubinstein A; Raz I; Abramsky O
Eur J Clin Pharmacol; 1984; 27(4):501-3. PubMed ID: 6440792
[TBL] [Abstract][Full Text] [Related]
29. Derivatives of valproic acid are active against pentetrazol-induced seizures in immature rats.
Mareš P; Kubová H; Hen N; Yagen B; Bialer M
Epilepsy Res; 2013 Sep; 106(1-2):64-73. PubMed ID: 23815889
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetic analysis of ester prodrugs of valproic acid.
Hadad S; Vree TB; van der Kleijn E; Bialer M
J Pharm Sci; 1992 Oct; 81(10):1047-50. PubMed ID: 1432619
[TBL] [Abstract][Full Text] [Related]
31. Polycomb homologs are involved in teratogenicity of valproic acid in mice.
Okada A; Aoki Y; Kushima K; Kurihara H; Bialer M; Fujiwara M
Birth Defects Res A Clin Mol Teratol; 2004 Nov; 70(11):870-9. PubMed ID: 15523661
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic analysis and anticonvulsant activity of two polyesteric prodrugs of valproic acid.
Hadad S; Vree TB; van der Kleijn E; Bialer M
Biopharm Drug Dispos; 1993 Jan; 14(1):51-9. PubMed ID: 8427944
[TBL] [Abstract][Full Text] [Related]
33. Effects of amoxicillin/clavulanic acid on the pharmacokinetics of valproic acid.
Lee SY; Huh W; Jung JA; Yoo HM; Ko JW; Kim JR
Drug Des Devel Ther; 2015; 9():4559-63. PubMed ID: 26309401
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid.
Kaufmann D; Yagen B; Minert A; Wlodarczyk B; Finnell RH; Schurig V; Devor M; Bialer M
Neuropharmacology; 2010 Jun; 58(8):1228-36. PubMed ID: 20230843
[TBL] [Abstract][Full Text] [Related]
35. Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
Okada A; Kushima K; Aoki Y; Bialer M; Fujiwara M
Birth Defects Res A Clin Mol Teratol; 2005 Apr; 73(4):229-38. PubMed ID: 15799026
[TBL] [Abstract][Full Text] [Related]
36. Design and pharmacological activity of glycinamide and N-methoxy amide derivatives of analogs and constitutional isomers of valproic acid.
Pessah N; Yagen B; Hen N; Shimshoni JA; Wlodarczyk B; Finnell RH; Bialer M
Epilepsy Behav; 2011 Nov; 22(3):461-8. PubMed ID: 21959082
[TBL] [Abstract][Full Text] [Related]
37. Stereoselective pharmacokinetic analysis of valnoctamide, a CNS-active chiral amide analogue of valproic acid, in dogs, rats, and mice.
Spiegelstein O; Yagen B; Bennett GD; Finnell RH; Blotnik S; Bialer M
Ther Drug Monit; 2000 Oct; 22(5):574-81. PubMed ID: 11034263
[TBL] [Abstract][Full Text] [Related]
38. An improved gas chromatographic determination of valproic acid and valpromide in plasma.
Pokrajac M; Miljković B; Spiridonović D; Varagić VM
Pharm Acta Helv; 1992; 67(8):237-40. PubMed ID: 1409759
[TBL] [Abstract][Full Text] [Related]
39. Valproic acid derivatives signal for apoptosis and repair in vitro.
Neuman MG; Nanau RM; Shekh-Ahmad T; Yagen B; Bialer M
Clin Biochem; 2013 Oct; 46(15):1532-7. PubMed ID: 23868021
[TBL] [Abstract][Full Text] [Related]
40. Histone deacetylases inhibition and tumor cells cytotoxicity by CNS-active VPA constitutional isomers and derivatives.
Eyal S; Yagen B; Shimshoni J; Bialer M
Biochem Pharmacol; 2005 May; 69(10):1501-8. PubMed ID: 15857614
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
